The Library
High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1
Tools
Tools
Tools
Singh, Harprit, Brindle, Nicholas P. J. and Zammit, Victor A. (2010) High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1. Microvascular Research, Vol.79 (No.2). pp. 121-127. doi:10.1016/j.mvr.2010.01.005 ISSN 0026-2862.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1016/j.mvr.2010.01.005
Abstract
Pre-diabetes is characterized by hyperglycemia and dyslipidemia, it is associated with increased cardiovascular disease and endothelial dysfunction. Angiopoietin-1 (Ang1). a ligand for endothelial receptor, is a potent vascular protective factor important in maintaining normal endothelial function The aim of the study was to examine the influence of elevated glucose and fatty acid concentrations oil angiopoietin signaling in human cardiac microvascular endothelial cells. Incubation with 30 mM glucose caused 50% suppression in the ability of Ang1 to activate Tie2-receptor phosphorylation without any decrease in Tie2 expression or increased internalization in microvascular endothelial cells Examination of downstream signaling revealed inhibition of Ang1-dependent Akt phosphorylation By contrast, Ang1 activation of Erk1/2 signaling was not affected by hyperglycemia. Similar suppression of Ang1-dependent activation of Akt by hyperglycemia was observed in large vessel human endothelial cells Incubation of microvascular endothelial cells with 200 mu M palmitic acid significantly inhibited Ang1-dependent Akt phosphorylation without affecting phosphorylation of the Tie-2 receptor or of ERK1/2 Therefore, contrary to hyperglycemia, palmitate acted exclusively downstream of the receptor The present findings suggest a mechanism by which increased glucose or fatty acids may suppress vascular protection by Ang1 and predispose to endothelial dysfunction and vascular disease. (C) 2010 Elsevier Inc All rights reserved
| Item Type: | Journal Article | ||||
|---|---|---|---|---|---|
| Subjects: | R Medicine > RC Internal medicine | ||||
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||
| Journal or Publication Title: | Microvascular Research | ||||
| Publisher: | Academic Press | ||||
| ISSN: | 0026-2862 | ||||
| Official Date: | March 2010 | ||||
| Dates: |
|
||||
| Volume: | Vol.79 | ||||
| Number: | No.2 | ||||
| Number of Pages: | 7 | ||||
| Page Range: | pp. 121-127 | ||||
| DOI: | 10.1016/j.mvr.2010.01.005 | ||||
| Status: | Peer Reviewed | ||||
| Publication Status: | Published | ||||
| Access rights to Published version: | Restricted or Subscription Access | ||||
| Funder: | Wellcome Trust | ||||
| Grant number: | 2008/09 |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
